These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 1794137
21. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Tsoi KK, Ng SS, Leung MC, Sung JJ. Aliment Pharmacol Ther; 2008 Aug 01; 28(3):353-63. PubMed ID: 18638075 [Abstract] [Full Text] [Related]
22. Risk factors in asymptomatic subjects screened for colorectal cancer. Griffiths EK, Shapira DV. Cancer Detect Prev; 1990 Aug 01; 14(6):647-50. PubMed ID: 2257563 [Abstract] [Full Text] [Related]
23. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka. Fujita M, Nakano Y, Ohta J, Kumanishi Y, Taguchi T. Cancer Detect Prev; 1987 Aug 01; 10(5-6):353-60. PubMed ID: 3568034 [Abstract] [Full Text] [Related]
24. Colon cancer screening: where have we come from and where do we go? Chorost MI, Datta R, Santiago RC, Lee B, Bollman J, Leitman IM, Ghosh BC. J Surg Oncol; 2004 Jan 01; 85(1):7-13. PubMed ID: 14696082 [No Abstract] [Full Text] [Related]
25. From colonic polyps to colon cancer: pathophysiology, clinical presentation, screening and colonoscopic therapy. Cappell MS. Minerva Gastroenterol Dietol; 2007 Dec 01; 53(4):351-73. PubMed ID: 18043553 [Abstract] [Full Text] [Related]
26. Immunological fecal occult blood test vs. serum ferritin for detection of colorectal neoplasia in high risk asymptomatic population. Sobrino-Cossío S, Fenocchi E, Hernández-Guerrero A, Alonso-Lárraga JO, De la Mora-Levy JG, Larracilla-Salazar I. Rev Gastroenterol Mex; 2011 Dec 01; 76(3):191-8. PubMed ID: 22041307 [Abstract] [Full Text] [Related]
27. [Prevention of colorectal cancer--sigmoidoscopy or colonoscopy]. Schusdziarra V. Z Gastroenterol; 1993 Dec 01; 31(12):758-9. PubMed ID: 8310731 [No Abstract] [Full Text] [Related]
28. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance. Bat L, Pines A, Ron E, Niv Y, Arditi E, Shemesh E. Am J Gastroenterol; 1986 Aug 01; 81(8):647-51. PubMed ID: 3740023 [Abstract] [Full Text] [Related]
30. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL, Smith A, Bampton PA, Cole SR, Young GP. Eur J Gastroenterol Hepatol; 2006 Oct 01; 18(10):1079-83. PubMed ID: 16957514 [Abstract] [Full Text] [Related]
33. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre. Manus B, Brägelmann R, Armbrecht U, Stolte M, Stockbrügger RW. Eur J Cancer Prev; 1996 Feb 01; 5(1):49-55. PubMed ID: 8664809 [Abstract] [Full Text] [Related]
36. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK, PLCO Project Team. J Natl Cancer Inst; 2005 Jul 06; 97(13):989-97. PubMed ID: 15998952 [Abstract] [Full Text] [Related]
38. Is full colonoscopic examination necessary in young patients with fresh bleeding per rectum? Khalid AB, Majid S, Salih M, Hashmat F, Jafri W. Endoscopy; 2011 Aug 06; 43(8):692-6. PubMed ID: 21448853 [Abstract] [Full Text] [Related]